| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.931 | 12.162 | 13.187 | 16.424 | 14.254 | 12.053 | 11.232 | 73.813 | 105.116 | 11.656 |
| Total Income - EUR | 11.931 | 12.162 | 13.187 | 16.424 | 14.254 | 12.053 | 11.232 | 73.813 | 105.116 | 11.656 |
| Total Expenses - EUR | 18.766 | 23.099 | 14.584 | 13.790 | 12.304 | 11.908 | 10.642 | 59.002 | 58.856 | 22.481 |
| Gross Profit/Loss - EUR | -6.835 | -10.938 | -1.396 | 2.634 | 1.950 | 145 | 589 | 14.811 | 46.260 | -10.825 |
| Net Profit/Loss - EUR | -7.193 | -11.181 | -1.528 | 2.475 | 1.807 | 28 | 479 | 14.088 | 45.230 | -11.133 |
| Employees | 3 | 6 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Check the financial reports for the company - Glaucos Medical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.453 | 29.856 | 29.808 | 29.261 | 29.727 | 43.535 | 59.284 | 11.684 | 9.134 | 6.663 |
| Current Assets | 8.141 | 1.749 | 1.427 | 1.660 | 1.174 | 1.720 | 1.851 | 18.681 | 56.333 | 3.393 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.988 | 0 | 0 | 0 | 241 | 152 | 149 | 12.286 | 34.248 | 2.227 |
| Cash | 4.153 | 1.749 | 1.427 | 1.660 | 932 | 1.568 | 1.703 | 6.395 | 22.085 | 1.166 |
| Shareholders Funds | 19.753 | 8.370 | 6.700 | 9.053 | 10.685 | 10.511 | 10.756 | 19.078 | 50.190 | 4.602 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.520 | 23.235 | 24.534 | 21.868 | 20.216 | 34.745 | 50.379 | 11.287 | 15.276 | 5.455 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Glaucos Medical S.r.l.